版本:
中国

BRIEF-Novartis says data back AMG 334 (erenumab) in migraine

June 9 Novartis AG

* Novartis says presents data demonstrating efficacy of amg 334 (erenumab) in migraine prevention at the american headache society annual meeting Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐